CD8A and melanoma: In addition, the use of multiplexed immunofluorescence highlighted a potential predictive role for specific cancer-associated fibroblasts (39) and CD103+ tumor-resident CD8+ T cells (29) in melanoma patients treated with anti-PD-1 therapy.